The Michael J. Fox Foundation (MJFF) is sponsoring a US $2 million prize (approx. AUD $2.6M) to the first team to develop a viable selective alpha–synuclein PET tracer and agree to make that tracer available broadly.
Eligibility
Contestants may be MJFF funded or not and can be from either academia or industry.
Contest rules:
- Contestants must apply for the prize with pre-clinical and clinical data supporting the broad use of their alpha-synuclein radiotracer. Judges may ask for additional data, including but not limited to raw imaging data.
- The winning contestant must demonstrate that the radiotracer binds with relatively high selectivity to alpha-synuclein according to pre-specified criteria and must demonstrate proof-of-concept in human subjects, including people with Parkinson’s disease and/or another synucleinopathy.
NOTE: All contestants must agree to make the winning radiotracer available for use by The Michael J. Fox Foundation and MJFF awardees through a nonexclusive license or other MJFF-approved mechanism.
Submission Requirements
- Applications may be submitted at anytime.
- Please contact Research Services to discuss your submission: